Other

Plan Assets For Deferred Compensation Fair Value Disclosure

Biogen Plan Assets For Deferred Compensation Fair Value Disclosure increased by 8.8% to $56.80M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: other_plan_assets_for_deferred_compensation_fair_value_d_0e274b

Historical Data

2 periods
 Q4 '25Q1 '26
Value$52.20M$56.80M
QoQ Change—+8.8%
Range$52.20M – $56.80M

Frequently Asked Questions

What is Biogen's plan assets for deferred compensation fair value disclosure?
Biogen (BIIB) reported plan assets for deferred compensation fair value disclosure of $56.80M in Q1 2026.